⟵ Back to Search Results

BGB-16673-101

Recruiting

A Phase 1 Dose-Escalation and Expansion Study of BGB-16673 in Patients With B-Cell Malignancies

Beigene Study ID info

BGB-16673-101

ClinicalTrials.gov ID info

NCT05006716

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents